Heyman Tomas J.
SEC insider (Form 3/4/5 filer). CIK 0001814673. Director at Legend Biotech Corp (LEGN) and 3 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in BRIDGEWATER, NJ.
Companies Heyman Tomas J. has filed insider reports for
- Legend Biotech Corp (LEGN): Director
- EXELIXIS, INC. (EXEL): Director
- Akero Therapeutics, Inc. (AKRO): Director
- OptiNose, Inc. (OPTN): Director
Heyman Tomas J.
CIK: 0001814673
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 24, 2026LEGN
Legend Biotech Corp
AwardDirect21K shares- - May 27, 2026EXEL
EXELIXIS, INC.
AwardDirect8.4K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect9.4K shares- - Jun 3, 2025AKRO
Akero Therapeutics, Inc.
AwardDirect9.4K shares- - May 29, 2025EXEL
EXELIXIS, INC.
AwardDirect9.8K shares- - May 21, 2025EXEL
EXELIXIS, INC.
SaleDirect4.5K shares at avg. $44.29$201K - May 21, 2025OPTN
OptiNose, Inc.
DispositionDirectStock Option (Right to Buy)
5K shares- - May 21, 2025OPTN
OptiNose, Inc.
DispositionDirectStock Option (Right to Buy)
3.6K shares- - May 21, 2025OPTN
OptiNose, Inc.
DispositionDirectStock Option (Right to Buy)
2.1K shares- - May 21, 2025OPTN
OptiNose, Inc.
DispositionDirectStock Option (Right to Buy)
962 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 |  LEGN Legend Biotech Corp | Award | 20,986 | - | $0 | Direct |
| May 27, 2026 |  EXEL EXELIXIS, INC. | Award | 8,367 | - | $0 | Direct |
| Dec 9, 2025 |  AKRO Akero Therapeutics, Inc. | Disposition | 9,398 | - | - | Direct |
| Jun 3, 2025 | AKRO Akero Therapeutics, Inc. | Award | 9,398 | - | - | Direct |
| May 29, 2025 | EXEL EXELIXIS, INC. | Award | 9,812 | - | - | Direct |
| May 21, 2025 | EXEL EXELIXIS, INC. | Sale | 4,544 | $44.29 | $201,254 | Direct |
| May 21, 2025 |  OPTN OptiNose, Inc. | Disposition Stock Option (Right to Buy) | 5,000 | - | - | Direct |
| May 21, 2025 | OPTN OptiNose, Inc. | Disposition Stock Option (Right to Buy) | 3,566 | - | - | Direct |
| May 21, 2025 | OPTN OptiNose, Inc. | Disposition Stock Option (Right to Buy) | 2,133 | - | - | Direct |
| May 21, 2025 | OPTN OptiNose, Inc. | Disposition Stock Option (Right to Buy) | 962 | - | - | Direct |
1-10 of 11 transactions